Intelligent Bio Solutions INBS
NASDAQ INBS
$1.67 +0.04 (+2.45%)
As of: Sep 30, 2026 · 2:38 PM EDT

Intelligent Bio Solutions (INBS) Short term Debt (2020)

Updated

Intelligent Bio Solutions (INBS) recorded Short term Debt of $5.13 million in fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Intelligent Bio Solutions (INBS) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Intelligent Bio Solutions 2.43 Mn -11.04 Mn 536,583.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 5.13 Mn
API Access

Intelligent Bio Solutions Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=INBS&period=max&api_key=YOUR_API_KEY